close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NASDAQ:ATOS

Recent news which mentions NASDAQ:ATOS

ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q2 2024
Tickers ATOS
Tags Earnings Reports Market News ATOS
From InvestorPlace
ATOS Stock Earnings: Atossa Therapeutics Beats EPS for Q1 2024
Tickers ATOS
Tags Market News ATOS Earnings Reports
From InvestorPlace
ATOS Stock Earnings: Atossa Therapeutics Misses EPS for Q4 2023
Tickers ATOS
Tags NASDAQ:ATOS Earnings Reports Market News
From InvestorPlace
Atossa Therapeutics backing Endoxifen in the fight against breast cancer
Tickers ATOS
Tags NASDAQ:ATOS
From News Direct
Atossa Therapeutics announces 30% enrollment for Phase 2 I-Spy breast cancer clinical trial
Tags NASDAQ:ATOS
From News Direct
Atossa Therapeutics announces further patent protection for Endoxifen
Tags NASDAQ:ATOS
From News Direct
ATOS Stock Holders Should Mark Their Calendars for Oct. 7
Tickers ATOS
Tags Market News ATOS NASDAQ:ATOS
From InvestorPlace
As its Meme Status Has Come and Gone, Skip Out on Atossa Therapeutics Stock
Tickers ATOS
Tags Hot Stocks NASDAQ:ATOS Market News
From InvestorPlace
With Zero Revenue, I Can’t Get Excited About Atossa
Tickers ATOS
Tags Stocks to Sell NASDAQ:ATOS Market News
From InvestorPlace
The Bear Case for Atossa Therapeutics Makes More Sense at This Time
Tickers ATOS
Tags Stocks to Sell NASDAQ:ATOS ATOS
From InvestorPlace
ATOS Stock: The Big News That Has Atossa Therapeutics Plunging 20% Today
Tickers ATOS
Tags Today's Market NASDAQ:ATOS Market News
From InvestorPlace
Wait for Atossa Therapeutics Stock to Slide Further Before Buying
Tickers ATOS
Tags NASDAQ:ATOS Market News ATOS
From InvestorPlace
A Promising Covid-19 Treatment Makes Atossa Therapeutics Intriguing
Tickers ATOS
Tags Stocks to Buy Market News ATOS
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today